Iyengar, Sunil <br/><br/>
P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse.  [electronic resource] 

 -  Blood  Mar 2013 
 - 2274-84 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2012-10-460832  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Line, Tumor<br/>Class I Phosphatidylinositol 3-Kinases<br/>DNA Mutational Analysis<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Expression Regulation, Enzymologic--physiology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--administration & dosage<br/>Purines--administration & dosage<br/>Quinazolinones--administration & dosage<br/>Recurrence<br/>Signal Transduction--physiology<br/>Substrate Specificity<br/>Treatment Outcome